All Stocks
B

BLTE

Belite Bio, Inc
Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$169.85

Market Cap

$6.68B

Beta

-1.46

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-95.76%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio—
FCF Yield-0.16%
Debt / Equity0.00
Interest Coverage999.0x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for BLTE.